XBiotech Inc.
XBIT
$2.42
-$0.02-0.82%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.51M | -26.89M | -6.01M | -1.76M | -10.88M |
| Total Depreciation and Amortization | 332.00K | 378.00K | 427.00K | 439.00K | 442.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.30M | -1.00M | 1.23M | -2.97M | 3.05M |
| Change in Net Operating Assets | -5.10M | 4.57M | 96.00K | -1.70M | 677.00K |
| Cash from Operations | -8.97M | -22.95M | -4.26M | -5.99M | -6.72M |
| Capital Expenditure | -- | -34.00K | -110.00K | -51.00K | -94.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.00K | -- | -- | -- | -- |
| Cash from Investing | 9.00K | -34.00K | -110.00K | -51.00K | -94.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -10.25M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 0.00 | 0.00 | 0.00 | -10.25M |
| Foreign Exchange rate Adjustments | -1.13M | 1.17M | -1.20M | 3.08M | 284.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.09M | -21.82M | -5.57M | -2.96M | -16.78M |